Neurotrophic Keratitis

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neurotrophic Keratitis Trial (BRM424 Ophthalmic Solution, Vehicle)

Not yet recruiting
  • Neurotrophic Keratitis
  • (no location specified)
Jun 28, 2023

Neurotrophic Corneal Ulcer, Neurotrophic Keratitis, Cranial Nerve V Diseases Trial in Palo Alto (Corneal neurotization)

Terminated
  • Neurotrophic Corneal Ulcer
  • +2 more
  • Corneal neurotization
  • Palo Alto, California
    Andrea Kossler
Mar 29, 2023

Corneal Disease, Neuropathy, Dry Eye Disease Trial (Quantitative Sensory Test)

Not yet recruiting
  • Corneal Disease
  • +3 more
  • Quantitative Sensory Test
  • (no location specified)
Feb 24, 2023

Neurotrophic Keratitis Trial in Canada (Insulin, Tarsorrhaphy)

Recruiting
  • Neurotrophic Keratitis
  • Edmonton, Alberta, Canada
  • +5 more
Feb 2, 2023

DEFENDO Long Term Follow-up Study in Stage 1 NK Patients

Not yet recruiting
  • Neurotrophic Keratitis
  • Cenegemin in the DEFENDO Study
  • San Diego, California
  • +2 more
Dec 12, 2022

Corneal Nerves After Treatment With Cenegermin

Recruiting
  • Neurotrophic Keratitis
  • Cenegermin Ophthalmic Solution [Oxervate]
  • Los Angeles, California
    University of California, Los Angeles
Oct 14, 2022

Diabetic Retinopathy Severity Scale With Level of Decreased

Recruiting
  • Diabetic Retinopathy
  • Neurotrophic Keratitis
    • San Antonio, Texas
      Medical Center Ophthalmology Associates
    Sep 30, 2022

    Neurotrophic Keratitis Trial in United States (CSB-001 Ophthalmic Solution 0.1%, Vehicle Control)

    Recruiting
    • Neurotrophic Keratitis
    • CSB-001 Ophthalmic Solution 0.1%
    • Vehicle Control
    • Loma Linda, California
    • +25 more
    Jun 22, 2022

    Neurotrophic Ulcer Following Treatment With Oxervate

    Recruiting
    • Neurotrophic Ulcer
    • +3 more
    • Cenegermin-Bkbj 0.002% Ophthalmic Solution [OXERVATE]
    • Manhasset, New York
      SightMD
    May 3, 2022

    Neurotrophic Keratitis Trial in United States (cenegermin-bkbj)

    Completed
    • Neurotrophic Keratitis
    • San Diego, California
    • +4 more
    Apr 11, 2022

    Neurotrophic Keratitis Trial in United States (rhNGF 20µg/ml, Placebo)

    Completed
    • Neurotrophic Keratitis
    • rhNGF 20µg/ml
    • Placebo
    • Loma Linda, California
    • +11 more
    Mar 31, 2022

    Nerve Growth Factor for the Treatment of Cornea Disease

    Completed
    • Neurotrophic Keratitis
    • Stanford, California
      Stanford University
    Dec 10, 2021

    Neurotrophic Keratitis Trial in Worldwide (Udonitrectag, Vehicle)

    Recruiting
    • Neurotrophic Keratitis
    • Crystal River, Florida
    • +23 more
    Oct 20, 2021

    Neurotrophic Keratitis Trial in Strasbourg (Miniinvasive corneal neurotization)

    Terminated
    • Neurotrophic Keratitis
    • Miniinvasive corneal neurotization
    • Strasbourg, France
      Les Hôpitaux Universitaires
    Sep 13, 2021

    Results in Neurotrophic Keratopathy in Stages 2 and 3

    Completed
    • Corneal Ulcer
    • +3 more
    • Topical Insulin
    • Vila Nova de Gaia, Portugal
      Centro Hospitalar Vila Nova de Gaia e Espinho
    Apr 24, 2021

    Neurotrophic Keratitis, Keratitis, Corneal Ulcer Trial in Worldwide (rhNGF 10 µg/ml, rhNGF 20 µg/ml, vehicle)

    Completed
    • Neurotrophic Keratitis
    • +2 more
    • rhNGF 10 μg/ml
    • +2 more
    • Dijon, France
    • +33 more
    Jul 26, 2019

    Neurotrophic Keratitis Trial in Spain (PRGF-Endoret, Artificial tears eye-drops)

    Unknown status
    • Neurotrophic Keratitis
    • Oviedo, Asturias, Spain
    • +3 more
    Jul 12, 2017